한글목차

세계의 법의학 유전체학 시장은 2024년에는 5억 8,715만 달러로 평가되었고, 2030년까지는 13억 4,726만 달러에 이를 것으로 예측되며, 예측 기간 중의 CAGR은 14.85%를 나타낼 전망입니다.

이 시장은 비용 효율적인 법의학 테스트 기술에 대한 정부 및 민간 부문의 자금 지원 증가에 힘입어 눈에 띄게 확장되고 있습니다. 여기에는 전 세계 국영 법의학 연구소의 물리적 증거 분석 역량 강화가 포함됩니다. 특히 국제 및 국내 공항의 보안 문제와 범죄 활동의 증가로 인해 첨단 법의학 솔루션에 대한 수요가 더욱 증가하고 있습니다. 법의학 과학의 발전에 힘입어 법의학 부서에서 최첨단 장비를 도입하면서 수사 효율성 또한 향상되고 있습니다. 또한 범죄를 해결하기 위해 게놈 기술에 대한 법 집행 기관의 의존도가 높아지면서 시장 성장이 촉진되고 있습니다. 특히, 상아 밀수 네트워크를 추적하기 위해 DNA를 사용하는 워싱턴 대학과 미국 국토안보부의 2022년 이니셔티브와 같은 공동 연구는 글로벌 보안 운영에서 법의학 게놈학의 역할이 확대되고 있음을 잘 보여줍니다.

주요 시장 성장 촉진요인

범죄율 증가와 고급 법의학 솔루션에 대한 수요

주요 시장 과제

윤리적 우려와 데이터 프라이버시 문제

주요 시장 동향

법의학 유전체학에서 인공지능과 머신러닝의 통합

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 법의학 유전체학 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 컴포넌트별(키트, 분석기 및 시퀀서, 소프트웨어, 소모품)
  • 방법별(모세관 전기영동법(CE), 차세대 시퀀싱(NGS), PCR 증폭)
  • 용도별(범죄 감정, 친자 감정 및 가족 감정, 바이오 디펜스, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 컴포넌트별
  • 방법별
  • 용도별
  • 지역별

제6장 북미의 법의학 유전체학 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 법의학 유전체학 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 법의학 유전체학 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 법의학 유전체학 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 법의학 유전체학 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 세계의 법의학 유전체학 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협/서비스

제15장 경쟁 구도

• Illumina, Inc.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Thermo Fischer Scientific, Inc.
• QIAGEN NV
• GE Healthcare
• Gene by Gene, Ltd.
• Neogen Corporation
• Eurofins Scientific SE
• Othram Inc.

제16장 전략적 제안

제17장 기업 소개와 면책사항

영문목차

The Global Forensic Genomics Market was valued at USD 587.15 million in 2024 and is projected to reach USD 1347.26 million by 2030, growing at a CAGR of 14.85% during the forecast period. The market is experiencing notable expansion, driven by increased funding from both governmental and private sectors for cost-efficient forensic testing technologies. This includes enhanced capabilities for analyzing physical evidence in state-run forensic labs globally. Rising security concerns, especially at international and domestic airports, coupled with the growing prevalence of criminal activities, are further fueling demand for advanced forensic solutions. The adoption of cutting-edge equipment in forensic departments, bolstered by advancements in forensic science, is also enhancing investigative efficiency. Additionally, law enforcement agencies' growing reliance on genomic technologies to solve crimes is propelling market growth. Notably, collaborative research, such as the 2022 initiative by the University of Washington and U.S. Department of Homeland Security using DNA to trace ivory smuggling networks, exemplifies the expanding role of forensic genomics in global security operations.

Key Market Drivers

Increasing Crime Rates and Demand for Advanced Forensic Solutions

The rise in violent crime globally is a key factor propelling the forensic genomics market, as law enforcement agencies turn to precise, advanced tools to improve investigative outcomes. Forensic genomics offers highly accurate DNA-based identification techniques crucial for solving complex cases. For instance, the FBI reported more than 1.3 million violent crimes in the U.S. in 2022. DNA technology has already been instrumental in resolving over 50,000 cases from 2010 to 2020, according to the U.S. Department of Justice. These figures underline the growing reliance on genomic analysis for cold cases and active investigations, reinforcing the demand for innovative and reliable forensic tools.

Key Market Challenges

Ethical Concerns and Data Privacy Issues

Despite its benefits, forensic genomics raises substantial ethical and data privacy concerns that hinder broader adoption. The practice of collecting and storing DNA-sometimes without clear consent-raises issues around individual rights and potential misuse. For example, collecting genetic material from suspects or their relatives can lead to questions about voluntary participation. Long-term storage of genetic profiles in national databases has sparked fears of surveillance and genetic discrimination. Regulatory bodies like the EU's GDPR impose strict controls on genetic data handling, while advocacy groups such as the ACLU and EFF have voiced concerns about the absence of comprehensive legal safeguards, especially in countries like the United States. These ethical dilemmas could limit public acceptance and regulatory flexibility.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Forensic Genomics

Artificial intelligence and machine learning are increasingly being integrated into forensic genomics to manage and analyze complex genomic data. AI-driven tools help streamline the interpretation of genetic information by identifying patterns and resolving DNA mixtures from multiple contributors-an essential capability in forensic investigations. Machine learning also enhances phenotypic prediction, enabling law enforcement to deduce physical traits from DNA when suspect databases offer no direct matches. These innovations increase accuracy, reduce turnaround times, and support real-time decision-making in active cases, signaling a technological shift toward automated and scalable forensic solutions.

Key Market Players

• Illumina, Inc.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Thermo Fischer Scientific, Inc.
• QIAGEN N.V.
• GE Healthcare
• Gene by Gene, Ltd.
• Neogen Corporation
• Eurofins Scientific SE
• Othram Inc.

Report Scope:

In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Forensic Genomics Market, By Component:

• Kits
• Analyzers & Sequencers
• Software
• Consumables

Forensic Genomics Market, By Technique:

• Capillary Electrophoresis (CE)
• Next-generation Sequencing (NGS)
• PCR Amplification

Forensic Genomics Market, By Application:

• Criminal Testing
• Paternity & Familial Testing
• Biodefense
• Others

Forensic Genomics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Forensic Genomics Market.

Available Customizations:

Global Forensic Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Forensic Genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Kits, Analyzers & Sequencers, Software, Consumables)
  • 5.2.2. By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification)
  • 5.2.3. By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Component
  • 5.3.2. By Technique
  • 5.3.3. By Application
  • 5.3.4. By Region

6. North America Forensic Genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Forensic Genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Forensic Genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Forensic Genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application

7. Europe Forensic Genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Forensic Genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. Germany Forensic Genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Forensic Genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Forensic Genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Forensic Genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. Asia-Pacific Forensic Genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Forensic Genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. India Forensic Genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Forensic Genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Forensic Genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Forensic Genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application

9. South America Forensic Genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Forensic Genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Forensic Genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Forensic Genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. Middle East and Africa Forensic Genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Forensic Genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Forensic Genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Forensic Genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Forensic Genomics Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Illumina, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Verogen, Inc.
• 15.3. Agilent Technologies, Inc.
• 15.4. Thermo Fischer Scientific, Inc.
• 15.5. QIAGEN N.V.
• 15.6. GE Healthcare
• 15.7. Gene by Gene, Ltd.
• 15.8. Neogen Corporation
• 15.9. Eurofins Scientific SE
• 15.10. Othram Inc.

16. Strategic Recommendations

17. About Us & Disclaimer